117. Syringomyelia Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 3 / Drugs : 5 - (DrugBank : 1) / Drug target gene : 0 - Drug target pathway : 0
| Other names | - | ||
|---|---|---|---|
| Disease group | Neuromuscular diseases | ||
|
Domestic patients
Med expenses recipients (FY2023) |
636 patients Age distribution
 💬 |
||
| Related info (in Japanese) | - | ||
| Clinical research form [April 1, 2025 ~] (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 11-1-3. Spinal lipoma | ||
| Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 117-1. | Symptomatic syringomyelia; | 11-1-3. Spinal lipoma | |
| 117-2. | Asymptomatic syringomyelia; | 11-1-3. Spinal lipoma | |
| 117-3. | Syringomyelia with Chiari I malformation; | 11-1-3. Spinal lipoma | |
| 117-4. | Syringomyelia with Chiari II malformation; | 11-1-3. Spinal lipoma | |
| 117-5. | Syringomyelia without Chiari malformation; | 11-1-3. Spinal lipoma | |
| 117-6. | Secondary syringomyelia; | 11-1-3. Spinal lipoma | |
| 117-7. | Idiopathic syringomyelia; | 11-1-3. Spinal lipoma | |